Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced Melanoma

ConclusionThe results showed high rates of objective response, RFS, and OS for patients undergoing immune profile-directed neoadjuvant immunotherapy for locally advanced melanoma. Furthermore, the study showed that treatment stratification based upon Tex frequency can potentially limit the adverse events associated with combination immunotherapy. These data merit further investigation with a larger validation study.
Source: Annals of Surgical Oncology - Category: Cancer & Oncology Source Type: research